Head of Clinical Development, Pulse
from
Since 2020, Sword has expanded across Musculoskeletal, Women’s Health, Cardiometabolic, and Mental Health, and is now moving beyond the session to a fully AI-native, 24/7 care program that brings physical activity, therapeutic exercise, psychotherapy, nutrition, and behavior change into one connected experience. More than 1 million members across three continents have completed over 15 million AI sessions, helping 2,000+ enterprise clients avoid more than $1 billion in unnecessary healthcare costs. Backed by 59 clinical studies, 43 patents, and more than $500 million raised from leading investors including Khosla Ventures, General Catalyst, and Founders Fund, Sword is defining a new standard for healthcare.
Role
We are seeking a Head of Clinical Development to drive clinical outcomes in Pulse, Sword's AI cardiometabolic care solution spanning hypertension, pre-diabetes, and GLP-1 support. This is a strategic and tactical role working closely with Product, Go-to-Market, Clinical Ops and, Clinical Affairs & Research team, reporting directly to the General Manager and working closely with the Chief Medical Officer and SVP for Clinical & Regulatory Affairs.
You will partner crossfunctionally to make sure clinical requirements are reflected accurately in product features, AI behavior, operational workflows, member experiences, and external communications. The role covers real breadth: clinical program architecture, external clinical credibility and thought leadership for go-to-market, clinical input into product development, clinical governance of Pulse's AI-driven three-way chat experience, and clinical quality standards for Clinical Operations.